Lee; Jinbo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Jinbo.The latest application filed is for "compositions and methods for reducing tactile dysfunction, anxiety, and social impairment".

Company Profile

6.23.39

Lee; Jinbo - Cambridge MA
Lee; Jinbo - Andover MA
Lee; Jinbo - Acton MA
Lee; Jinbo - Southbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment Grant 11,434,244 - Ginty , et al. September 6, 2	2022-09-06
Compositions And Methods For Reducing Tactile Dysfunction, Anxiety, And Social Impairment App 20220162173 - Ginty; David D. ; et al.	2022-05-26
Uridine Nucleoside Derivatives, Compositions And Methods Of Use App 20220135611 - Haydon; Philip G. ; et al.	2022-05-05
Charged Ion Channel Blockers And Methods For Use App 20220041552 - Bean; Bruce P. ; et al.	2022-02-10
Uridine diphosphate derivatives, prodrugs, compositions and uses thereof Grant 11,241,450 - Haydon , et al. February 8, 2	2022-02-08
Synthetic Derivatives Of Cholic Acid 7-sulfate And Uses Thereof App 20220016138 - Devlin; Abigail Sloan ; et al.	2022-01-20
Uridine Diphosphate Derivatives, Compositions And Methods For Treating Neurodegenerative Disorders App 20210347807 - Haydon; Philip G. ; et al.	2021-11-11
Uridine nucleoside derivatives, compositions and methods of use Grant 11,124,536 - Haydon , et al. September 21, 2	2021-09-21
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders Grant 11,072,627 - Haydon , et al. July 27, 2	2021-07-27
Compositions And Methods For Reducing Tactile Dysfunction, Anxiety, And Social Impairment App 20210206771 - Ginty; David D. ; et al.	2021-07-08
Compositions And Methods For Reducing Tactile Dysfunction, Anxiety, And Social Impairment App 20210206714 - Ginty; David D. ; et al.	2021-07-08
Charged ion channel blockers and methods for use Grant 11,021,443 - Bean , et al. June 1, 2	2021-06-01
Uridine Diphosphate Derivatives, Prodrugs, Compositions And Uses Thereof App 20210069226 - Haydon; Philip G. ; et al.	2021-03-11
Uridine Nucleoside Derivatives, Compositions And Methods Of Use App 20200399302 - Haydon; Philip G. ; et al.	2020-12-24
Charged Ion Channel Blockers And Methods For Use App 20200377459 - Bean; Bruce P. ; et al.	2020-12-03
Charged Ion Channel Blockers And Methods For Use Thereof App 20200231545 - Bean; Bruce P. ; et al.	2020-07-23
Uridine diphosphate derivatives, prodrugs, compositions and uses thereof Grant 10,632,138 - Haydon , et al.	2020-04-28
Uridine Nucleoside Derivatives, Compositions And Methods Of Use App 20200040025 - Haydon; Philip G. ; et al.	2020-02-06
Uridine nucleoside derivatives, compositions and methods of use Grant 10,544,183 - Haydon , et al. Ja	2020-01-28
Uridine Diphosphate Derivatives, Compositions And Methods For Treating Neurodegenerative Disorders App 20190309009 - Haydon; Philip G. ; et al.	2019-10-10
Uridine nucleoside derivatives, compositions and methods of use Grant 10,138,265 - Haydon , et al. Nov	2018-11-27
Uridine Diphosphate Derivatives, Prodrugs, Compositions And Uses Thereof App 20180280421 - Haydon; Philip G. ; et al.	2018-10-04
Charged Ion Channel Blockers And Methods For Use App 20180237392 - BEAN; Bruce P. ; et al.	2018-08-23
Uridine Monophosphate And Triphosphate Derivatives, Compositions And Methods Of Use App 20180085386 - Haydon; Philip G. ; et al.	2018-03-29
Uridine diphosphate derivatives, prodrugs, compositions and uses thereof Grant 9,913,855 - Haydon , et al. March 13, 2	2018-03-13
Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders Grant 9,750,760 - Haydon , et al. September 5, 2	2017-09-05
Small molecule inhibitors of PI3-kinase signaling Grant 9,701,646 - Degterev , et al. July 11, 2	2017-07-11
Uridine Diphosphate Derivatives, Compositions And Methods For Treating Neurodegenerative Disorders App 20160318968 - Haydon; Philip G. ; et al.	2016-11-03
Halofuginone Analogs For Inhibition Of Trna Synthetases And Uses Thereof App 20160317498 - Keller; Tracy ; et al.	2016-11-03
Small Molecule Inhibitors Of Pi3-kinase Signaling App 20160297777 - Degterev; Alexei ; et al.	2016-10-13
Uridine Diphosphate Derivatives, Prodrugs, Compositions And Methods For Treating Neurodegenerative Disorders App 20160243148 - Haydon; Philip G. ; et al.	2016-08-25
Uridine Nucleoside Derivatives, Compositions And Methods Of Use App 20160075731 - Haydon; Philip G. ; et al.	2016-03-17
Halofuginone analogs for inhibition of tRNA synthetases and uses thereof Grant 9,284,297 - Keller , et al. March 15, 2	2016-03-15
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders Grant 9,227,993 - Haydon , et al. January 5, 2	2016-01-05
Methods for treating glaucoma using uridine diphosphate derivatives Grant 9,163,055 - Haydon , et al. October 20, 2	2015-10-20
Uridine Diphosphate Derivatives, Prodrugs, Compositions And Uses Thereof App 20150265647 - Haydon; Philip G. ; et al.	2015-09-24
Uridine Diphosphate Derivatives, Compositions And Methods For Treating Neurodegenerative Disorders App 20150045319 - Haydon; Philip G. ; et al.	2015-02-12
Uridine Nucleoside Derivatives, Compositions And Methods Of Use App 20140371167 - Haydon; Philip G. ; et al.	2014-12-18
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders Grant 8,785,620 - Haydon , et al. July 22, 2	2014-07-22
Uridine Diphosphate Derivatives, Prodrugs, Compositions And Methods For Treating Neurodegenerative Disorders App 20140162972 - Haydon; Philip G. ; et al.	2014-06-12
Uridine Diphosphate Derivatives, Compositions And Methods For Treating Neurodegenerative Disorders App 20140066613 - Haydon; Philip ; et al.	2014-03-06
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders Grant 8,598,141 - Haydon , et al. December 3, 2	2013-12-03
Uridine Diphosphate Derivatives, Compositions And Methods For Treating Neurodegenerative Disorders App 20130252919 - Haydon; Philip ; et al.	2013-09-26
Macrocyclic compounds for inhibition of tumor necrosis factor alpha Grant 8,338,565 - Lee , et al. December 25, 2	2012-12-25
Halofuginone Analogs For Inhibition Of Trna Synthetases And Uses Thereof App 20110263532 - Keller; Tracy ; et al.	2011-10-27
Macrocyclic Compounds For Inhibition Of Tumor Necrosis Factor Alpha App 20100152099 - Lee; Jinbo ; et al.	2010-06-17
PTP1b inhibitors Grant 7,674,822 - Lee , et al. March 9, 2	2010-03-09
11-Beta HSD1 Inhibitors App 20100029648 - Xiang; Jason Shaoyun ; et al.	2010-02-04
11-beta HSD1 inhibitors Grant 7,632,838 - Xiang , et al. December 15, 2	2009-12-15
Inhibitors of protein tyrosine phosphatase 1B Grant 7,521,473 - Lee , et al. April 21, 2	2009-04-21
Inhibitors of Protein Tyrosine Phosphatase 1B App 20090048286 - Lee; Jinbo ; et al.	2009-02-19
PTP1B inhibitors App 20080004325 - Lee; Jinbo ; et al.	2008-01-03
11-Beta HSD 1 inhibitors App 20070219198 - Xiang; Jason Shaoyun ; et al.	2007-09-20
PTP1b inhibitors App 20060135488 - Lee; Jinbo ; et al.	2006-06-22
Inhibitors of protein tyrosine phosphatase 1B App 20050203087 - Lee, Jinbo ; et al.	2005-09-15
Inhibitors of protein tyrosine phosphatase 1B App 20050203081 - Lee, Jinbo ; et al.	2005-09-15
Substituted benzimidazole compounds Grant 6,825,219 - Cywin , et al. November 30, 2	2004-11-30
Substituted benzimidazole compounds App 20030144281 - Cywin, Charles ; et al.	2003-07-31
Small molecules useful in the treatment of inflammatory disease App 20030008848 - Fleck, Roman Wolfgang ; et al.	2003-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.